|
Video: What is a Stock Split?
|
|
Marker Therapeutics is a clinical-stage immuno-oncology company. Co. focuses on the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease, as well as develops DNA expression technology. Co. is developing vaccines that target candidate breast cancer(s), colorectal cancer(s), ovarian cancer(s) and non-small cell lung cancer(s). Co.'s three primary technology platforms include: a licensed vaccine for the treatment of HER2/neu+ breast cancer; a licensed vaccine for treating breast and ovarian cancers; and a wholly owned DNA expression vaccine technology (Polystart) for treating various cancers or infectious disease. According to our TPIV split history records, TPIV has had 1 split. | |
|
TPIV (TPIV) has 1 split in our TPIV split history database. The split for TPIV took place on July 27, 2009. This was a 1 for 10 reverse split, meaning for each 10 shares of TPIV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as TPIV conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TPIV split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TPIV shares, starting with a $10,000 purchase of TPIV, presented on a split-history-adjusted basis factoring in the complete TPIV split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/11/2014 |
|
End date: |
10/17/2018 |
|
Start price/share: |
$0.35 |
|
End price/share: |
$8.34 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
2,282.86% |
|
Average Annual Total Return: |
127.90% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$238,270.69 |
|
Years: |
3.85 |
|
|
|
Date |
Ratio |
07/27/2009 | 1 for 10 |
|
|